Filing Details
- Accession Number:
- 0001179110-14-003838
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-27 17:05:28
- Reporting Period:
- 2014-02-27
- Filing Date:
- 2014-02-27
- Accepted Time:
- 2014-02-27 17:05:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1065087 | Albany Molecular Research Inc | AMRI | Services-Commercial Physical & Biological Research (8731) | 141742717 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1449207 | R Steven Hagen | 21 Corporate Circle Po Box 15098 Albany NY 12203 | Sr Vp Pharmaceutical Dev & Mfg | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-02-27 | 3,000 | $9.34 | 37,838 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-02-27 | 3,000 | $15.73 | 34,838 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Option to purchase Common Stock | Acquisiton | 2014-02-27 | 3,000 | $9.34 | 3,000 | $9.34 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2012-03-05 | 2017-03-05 | No | 4 | M | Direct |
Footnotes
- Grant was fully exercisable on 3/5/2012.